Strontium 89 Therapy for the Palliation of Pain Due to Osseous Metastases

Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer

1993 • 526 citations

Bone metastases: pathophysiology and management policy.

1991 • 479 citations

A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer

1994 • 337 citations

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone

1991 • 281 citations

Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate

1986 • 250 citations

Strontium-89 chloride for pain palliation in prostatic skeletal malignancy

1991 • 219 citations

Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.

1991 • 162 citations

Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer.

1992 • 146 citations

Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone.

1989 • 133 citations

Strontium-89 therapy for the pain of osseous metastases.

1985 • 125 citations

Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases

1992 • 90 citations

Radionuclide therapy of intractable bone pain: Emphasis on strontium-89

1992 • 74 citations

Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?

1992 • 71 citations

Clinical experience with strontium-89 in prostatic and breast cancer patients.

1993 • 68 citations

A retrospective analysis of the cost effectiveness of treatment with Metastron?? (89Sr-chloride) in patients with prostate cancer metastatic to bone

1994 • 64 citations

Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful osseous metastases.

1993 • 63 citations

[153Sm]EDTMP: A potential therapy for bone cancer pain

1992 • 63 citations

Prostate cancer. Primary hormonal treatment.

1993 • 51 citations

Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendations.

1994 • 49 citations

Clinical Practice Guideline Number 9 – Management of Cancer Pain

1995 • 44 citations

Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate.

1980 • 40 citations

Radiopharmaceuticals in clinical trials.

1993 • 26 citations

Strontium 89 for palliation of bone metastases.

1986 • 24 citations

Phosphorus-32 for intractable pain in carcinoma of prostate

1977 • 22 citations

Systemic radionuclide therapy of bone metastases with strontium-89.

1994 • 17 citations

Chemical Stability of Suramin in Commonly used Infusion Fluids

1990 • 13 citations

Rehabilitation in terminal cancer patients

1981 • 7 citations

Phosphorus 32 for intractable pain in carcinoma of the prostate.

1971 • 6 citations

Strontium-89 therapy in painful bony metastases

1993 • 5 citations

Why palliative medicine?

1991 • 4 citations

Incorporation of a New Radioactive Compound, 4+Sn-117m DTPA, Into Normal and Burred Rat Femurs

1986 • 1 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database